
Sign up to save your podcasts
Or


Dr Joshua Brody from The Tisch Cancer Institute in New York, Dr Matthew Lunning from the University of Nebraska Medical Center in Omaha and Dr Jason Westin from The University of Texas MD Anderson Cancer Center in Houston discuss chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia. Produced by Research To Practice.
CME information and select publications here.
By Dr. Neil Love4.9
5656 ratings
Dr Joshua Brody from The Tisch Cancer Institute in New York, Dr Matthew Lunning from the University of Nebraska Medical Center in Omaha and Dr Jason Westin from The University of Texas MD Anderson Cancer Center in Houston discuss chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia. Produced by Research To Practice.
CME information and select publications here.

141 Listeners

319 Listeners

500 Listeners

67 Listeners

32 Listeners

75 Listeners

14 Listeners

17 Listeners

13 Listeners

0 Listeners

118 Listeners

58 Listeners

3,355 Listeners

198 Listeners

43 Listeners

22 Listeners

363 Listeners

190 Listeners

41 Listeners

0 Listeners